Briefs: Alkem Laboratories and Zydus Lifesciences
USFDA inspects Zydus Lifesciences’ Ahmedabad SEZ Onco manufacturing plant
USFDA inspects Zydus Lifesciences’ Ahmedabad SEZ Onco manufacturing plant
The company disclosed that several employees of a subsidiary had their business email addresses stolen
The unit’s contribution to the company's revenue US$3.85 million in the last fiscal year
The company has received Form 483 with three observations
The countrywide initiative aims to spread awareness, educate the public & ensure that no one is left behind in the fight against respiratory diseases
The initiative will focus on advocating for cleaner air
Education on Inhalation Therapy & Conducting Nationwide Awareness Camps, Alkem Breathe Initiative Addresses the Alarming Increase in Respiratory Diseases in India
Biosergen AB is developing BSG005 for the treatment of severe and difficult-to-treat invasive fungal diseases
Introduces a line-up of brands targeting key therapeutic categories for its ophthalmology segment launc
Approximately 60 to 78% of individuals diagnosed with Asthma also have concurrent Allergic Rhinitis
Subscribe To Our Newsletter & Stay Updated